Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
Date:9/23/2009

tical Laboratories, Ltd., develops, manufactures, markets and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limitation, the words "believe" or "expect" and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission, including Part I, Item 1A of our most recent Form 10-K, and include but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or less expensive products or new technology for the production of products, the entry into the market of new competitors, market and customer acceptance and demand for new pharmaceutical products, availability of raw materials, timing and success of product development and launches, dependence on few products generating majority of sales, product liability claims for which the Company may be inadequately insured, material litigation from product recalls, the purported class action lawsuits alleging federal securities laws violations, delays in returning the Company's products to market, including loss of market share, increased reserves against the FDA-seized inventory, and other risks identified in this report and from time to time in our periodic reports and registration state
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
4. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
5. Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Dog Food Secrets , a guide compiled ... ingredients in most commercial dog food but presents a better ... of Shane Michaels, prompting an investigative review. , “For ... family member as any other human is, which is why ... should due to poor diet” reports Michaels. “Most dog owners ...
(Date:9/16/2014)... (PRWEB) September 17, 2014 Operation Smile was ... die because of a facial deformity.” To spread their message ... September 19, 2014, at the Beverly Wilshire Hotel in Beverly ... young people worldwide whose lives have been forever transformed by ... to be involved with Operation Smile,” said Lynda Erkiletian, Executive ...
(Date:9/16/2014)... In a healthcare climate where the costs ... a Yale study has found that radiation oncologists ... elderly women with early-stage breast cancer. The findings ... annual conference of the American Society for Radiation ... Practice in Radiotherapy for Elderly Women: Response to ...
(Date:9/16/2014)... (PRWEB) September 17, 2014 ... hosting suppliers from the USA and announces ... ) are the best Windows web hosting ... on offering worldwide clients high quality WordPress ... low rates. , HostMonster provides outstanding ...
(Date:9/16/2014)... Not all recovery plans are alike, and ... sure all their patients are receiving the treatment that ... the newly-introduced online therapy. Millennium Treatment Group recently launched ... opportunity to seek treatment from home. , With online ... care at a distance. They provide patients with all ...
Breaking Medicine News(10 mins):Health News:Dog Food Secrets: Review Exposes Andrew Lewis’ Guide to Happier, Healthier Dogs with Homemade Dog Food 2Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2Health News:Best Windows Web Hosting Suppliers Recommended By SEO Hosting Review Site Top10BestSEOHosting.com 2Health News:Millennium Treatment Group Now Offers Online Therapy 2
... C with the standard therapy of pegylated-interferon and ribavirin would ... of Hepatology, a journal published by John Wiley ... Study of Liver Diseases (AASLD). The article is also available ... prisons incarcerate more than 2 million inmates each year, and ...
... to Be Served Beginning in ... ... been awarded the five-year Active Duty Dental Program (ADDP),contract by the United ... be awarded to the Harrisburg, PA-based,national dental insurer. The contract, which is ...
... Some Payers Scaling Back Chronic Disease,Initiatives, WASHINGTON, ... to reports that many Americans are forgoing basic,medical ... renewed vigilance,in the fight against chronic disease and ... of belt-tightening make sense in tough economic times,--dining ...
... & Grossman, LLC,announces that a class action lawsuit has ... District of Colorado against The Spectranetics,Corporation. ("Spectranetics" or the ... of purchasers of Spectranetics who purchased common,stock between April ... According to the complaint, the true facts, which ...
... channel count 12-bit ADC with Samplify,s, Prism(TM) data ... in ... SANTA CLARA, Calif., Oct. 20 Samplify ... family of true,16-channel, 12-bit, 65 Msample/sec analog-to-digital converter ...
... 20 Concentric Medical,Inc., the global leader in ... announced the launch of the Merci(R) Distal Access,Catheter, ... and enhanced support during minimally invasive procedures in ... using the Merci Retrieval System(TM),to remove thrombus in ...
Cached Medicine News:Health News:Hepatitis C treatment is cost-effective for the US prison population 2Health News:National Dental Insurer United Concordia to Receive $660 Million Contract From U.S. Department of Defense 2Health News:Nation's Economic Downturn Threatens Continuity of Care for Chronic Conditions 2Health News:Bronstein, Gewirtz & Grossman, LLC Announces that a Class Action has been Filed Against The Spectranetics Corporation 2Health News:Samplify Systems Announces Availability of World's First 16-channel, 12-bit, 65 Msps A/D Converter With Integrated Real-Time Data Compression 2Health News:Samplify Systems Announces Availability of World's First 16-channel, 12-bit, 65 Msps A/D Converter With Integrated Real-Time Data Compression 3Health News:Samplify Systems Announces Availability of World's First 16-channel, 12-bit, 65 Msps A/D Converter With Integrated Real-Time Data Compression 4Health News:Samplify Systems Announces Availability of World's First 16-channel, 12-bit, 65 Msps A/D Converter With Integrated Real-Time Data Compression 5
(Date:9/16/2014)... -- Research and Markets has announced ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study ... devices. The report provides a basic ... and industry chain structure. The laparoscopic devices market ...
(Date:9/16/2014)... 16, 2014   Vestagen Technical Textiles, Inc. ... at hospitals. The myComfort™ line of patient apparel is ... that is fluid repellant, breathable and in studies done ... of bacteria on the fabric i . ... the chain of transmission. We want myComfort to be ...
(Date:9/16/2014)... BRIDGEWATER, N.J. , Sept. 16, 2014 /PRNewswire/ ... pharmaceutical company focused on developing and commercializing therapeutic ... renal and infectious diseases, announces the amendment and ... and E preferred stock and related warrants, as ... 2014 common stock and warrant financing, to remove ...
Breaking Medicine Technology:Global Laparoscopy Devices Industry Report 2014 2New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
... Pa., Feb. 16, 2011 AirPal, a medical device ... of allowance from the U.S. Patent Office for its ... for situations such as difficult airway management, laryngoscopies, diagnostic ... founded in 1982, now holds more than a dozen ...
... YORK, Feb. 16, 2011 Get content from ... The European Parliament is expected ... prevent falsified medicines from entering the legal distribution ... packages have reached patients in the last years. ...
Cached Medicine Technology:AirPal Receives Patent for Inflatable Patient Positioning Systems 2
Agarose IEF is suitable for isoelectric focusing of large molecules and is the gel of choice for many IEF applications and immunochemical detection methods....
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
... White solid. Highly purified non-ionic fraction of ... at very low concentrations. Can be mounted ... dried, films are elastic and durable and ... with either protein or lipoprotein dyes. ...
Medicine Products: